SANTA FE, N.M., Jan. 25, 2012 /PRNewswire/ -- Sigma Labs, Inc. (OTCBB: SGLB) announced today that, due to the Company's filing of three patents with the U.S. Patent and Trademark Office, it has made significant progress in increasing its licensable intellectual property ("IP") portfolio for its core technologies. The patent filings specifically cover real-time monitoring and control for nondestructive inspection of advanced manufacturing technologies, and novel material and joining technologies for advanced munitions.
Rich Mah, CEO of Sigma Labs, stated, "With these most recent patent filings, Sigma Labs has made significant progress toward our product goals. Also, our recent acquisition of Sumner Associates has already borne fruit, as Sumner Associates has introduced certain of our patent-pending products to a major munitions manufacturer, who has expressed interest in licensing these products from us. Mark Cola, President of Sigma Labs, added, "We now have stronger IP positions in our core product offerings through the new patent filings and through conversion from provisional to utility patent filings for our existing products. Further, a recent contract from a Fortune 100 aerospace company for our real-time monitoring technology confirms our company's ability to perform for large international organizations. These IP filings are a key part of our transformation to a primarily products-based business."
About Sigma Labs, Inc.
Sigma Labs, Inc. comprises leading scientists and engineers from Los Alamos National Laboratory with over 75 years of combined industrial R&D experience. They develop manufacturing and materials technologies and R&D solutions for first-tier integrators like Boeing, Honeywell, Pratt & Whitney, and other commercial firms around the globe. Sigma Labs, Inc. has current contracts with Federal Government and private industry clients to develop technologies from their conception through the design, building, and testing of prototype systems by integrating sensing, software, materials and manufacturing technology risk-reduction solutions. Visit Sigma Labs at www.sigmalabsinc.com.
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and our Report on Form 8-K that was filed in connection with the transaction we recently completed with B6 Sigma. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Sigma Labs, Inc.